Wei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Zhang has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Suying Dang
Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
17 shared publications Tiantian Lu
Key Laboratory of Brain Functional Genomics (Ministry of Education and Shanghai), School of Life Science, East China Normal University, Shanghai, China
9 shared publicationsTao Hong
Key Laboratory of Brain Functional Genomics (East China Normal University), Ministry of Education, Shanghai Key Laboratory of Brain Functional Genomics (East China Normal University), School of Life Science, East China Normal University, China
7 shared publications- Yi-Hsuan Pan
Key Laboratory of Brain Functional Genomics of Ministry of Education, School of Life Science, East China Normal University, Shanghai 200062, China
7 shared publications Ning Yang
Key Laboratory of Brain Functional Genomics (Ministry of Education and Shanghai), School of Life Sciences, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China
6 shared publicationsShuai Ye
Key Laboratory of Brain Functional Genomics (Ministry of Education and Shanghai), School of Life Sciences, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China
5 shared publications
Latest Publications
- 19 December 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 239, 106874
Expression and functional characterization of recombinant soluble CD40 Ligand in prokaryotic systems
- 19 December 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 239, 106874
Expression and functional characterization of recombinant soluble CD40 Ligand in prokaryotic systems
- Open Access
- 7 June 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-20
The secreted protease ADAMTS18 is a novel activator of latent TGF-β to exacerbate renal fibrosis
Renal fibrosis (RF) is an inevitable consequence of almost all forms of progressive chronic kidney disease (CKD). TGFβ is a powerful cytokine capable of dominating the fibrotic process. Targeting factors capable of activating latent TGF-β is a more effective and safe strategy to reduce TGF-β-induced fibrosis, but appropriate targets need to be identified. Here, we show that ADAMTS18/Adamts18 is significantly upregulated in the fibrotic kidneys of human CKD patients and mice. ADAMTS18 is primarily produced by renal tubular epithelial cells and fibroblasts during RF. Functionally, Adamts18 deletion inhibits epithelial-mesenchymal transition, inflammation, and collagen synthesis. Conversely, Adamts18 overexpression exacerbates progressive renal fibrosis. Mechanistically, the KPFR sequence in ADAMTS18 disrupts the latency-associated peptide (LAP) interaction with TGF-β and increases the release of mature TGF-β1. Blockage of ADAMTS18-mediated latent TGF-β activation by a tetrapeptide (LSKL) effectively reverses RF. Collectively, ADAMTS18 is a novel LAP-TGF-β1 activator with the potential to optimize CKD treatment strategies.
- 7 June 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-20
Open AccessThe secreted protease ADAMTS18 is a novel activator of latent TGF-β to exacerbate renal fibrosis
Renal fibrosis (RF) is an inevitable consequence of almost all forms of progressive chronic kidney disease (CKD). TGFβ is a powerful cytokine capable of dominating the fibrotic process. Targeting factors capable of activating latent TGF-β is a more effective and safe strategy to reduce TGF-β-induced fibrosis, but appropriate targets need to be identified. Here, we show that ADAMTS18/Adamts18 is significantly upregulated in the fibrotic kidneys of human CKD patients and mice. ADAMTS18 is primarily produced by renal tubular epithelial cells and fibroblasts during RF. Functionally, Adamts18 deletion inhibits epithelial-mesenchymal transition, inflammation, and collagen synthesis. Conversely, Adamts18 overexpression exacerbates progressive renal fibrosis. Mechanistically, the KPFR sequence in ADAMTS18 disrupts the latency-associated peptide (LAP) interaction with TGF-β and increases the release of mature TGF-β1. Blockage of ADAMTS18-mediated latent TGF-β activation by a tetrapeptide (LSKL) effectively reverses RF. Collectively, ADAMTS18 is a novel LAP-TGF-β1 activator with the potential to optimize CKD treatment strategies.
- 14 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 179
ADAMTS18 deficiency leads to abnormal brain methylation metabolism, dysregulated neuroinflammatory response, and unsound blood-brain barrier structure in mice
ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family is a group of secretory proteases involved in the maintenance of central nervous system (CNS) homeostasis and neuronal disease. ADAMTS18 is a member of this family and has been linked to the integrity of the human brain's white matter. However, the cellular and molecular basis of ADAMTS18 in brain metabolism and homeostasis remains unclear. In this study, a total of 47,719 genes were identified in 8 independent wild type (WT) and Adamts18 knockout (KO) mouse brain samples using brain transcriptomic analysis. The abundance of 100 genes in brain was significantly different between WT and KO mice. ADAMTS18 deficiency resulted in decreased S-adenosine homocysteine hydrolase (SAHH) levels, impaired brain methyl cycle metabolism and dysregulation of neuroinflammatory-related factors (e.g., Lrg1, and Lcn2) in mouse brain. The number and branching complexity of microglia in brain tissue of Adamts18 KO mice were significantly reduced. Adamts18 KO mice also showed poor blood-brain barrier (BBB) integrity. Mechanically, ADAMTS18 deficiency resulted in significant downregulation of Il- 34, Csf1r, Cx3cl1, Cx3cr1, Fn, Tgfb1, Tgfbr2, Smad4 and Sall1 genes related to microglia expansion, migration, characteristic development and maintenance. BBB integrity related markers Glut1, Plvap, Zo- 1, Occludin or Aqp- 4 were partially dysregulated in the brain tissue of Adamts18 KO mice and significantly deteriorated after LPS stimulation. Collectively, these results shed light on the significance of ADAMTS18 in brain methyl cycle metabolism, neuroinflammatory regulation and BBB structure maintenance.
- 14 April 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (4) , 179
ADAMTS18 deficiency leads to abnormal brain methylation metabolism, dysregulated neuroinflammatory response, and unsound blood-brain barrier structure in mice
ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family is a group of secretory proteases involved in the maintenance of central nervous system (CNS) homeostasis and neuronal disease. ADAMTS18 is a member of this family and has been linked to the integrity of the human brain's white matter. However, the cellular and molecular basis of ADAMTS18 in brain metabolism and homeostasis remains unclear. In this study, a total of 47,719 genes were identified in 8 independent wild type (WT) and Adamts18 knockout (KO) mouse brain samples using brain transcriptomic analysis. The abundance of 100 genes in brain was significantly different between WT and KO mice. ADAMTS18 deficiency resulted in decreased S-adenosine homocysteine hydrolase (SAHH) levels, impaired brain methyl cycle metabolism and dysregulation of neuroinflammatory-related factors (e.g., Lrg1, and Lcn2) in mouse brain. The number and branching complexity of microglia in brain tissue of Adamts18 KO mice were significantly reduced. Adamts18 KO mice also showed poor blood-brain barrier (BBB) integrity. Mechanically, ADAMTS18 deficiency resulted in significant downregulation of Il- 34, Csf1r, Cx3cl1, Cx3cr1, Fn, Tgfb1, Tgfbr2, Smad4 and Sall1 genes related to microglia expansion, migration, characteristic development and maintenance. BBB integrity related markers Glut1, Plvap, Zo- 1, Occludin or Aqp- 4 were partially dysregulated in the brain tissue of Adamts18 KO mice and significantly deteriorated after LPS stimulation. Collectively, these results shed light on the significance of ADAMTS18 in brain methyl cycle metabolism, neuroinflammatory regulation and BBB structure maintenance.
- Open Access
ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells
- Open Access
- 29 January 2024
- Published by Springer Nature in Breast Cancer Research
- Vol. 26 (1) , 1-14
ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis
Background: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer accounts for about 20% of all breast cancer cases and is correlated with a high relapse rate and poor prognosis. ADAMTS18 is proposed as an important functional tumor suppressor gene involved in multiple malignancies, including breast cancer. It functions as an extracellular matrix (ECM) modifier. However, it remains unclear whether ADAMTS18 affects mammary tumorigenesis and malignant progression through its essential ECM regulatory function. Methods: To elucidate the role of ADAMTS18 in HER2-positive mammary tumorigenesis and metastasis in vivo, we compared the incidence of mammary tumor and metastasis between Adamts18-knockout (MMTV)-Her2/ErbB2/Neu+ transgenic mice (i.e., Her2t/w/Adamts18−/−) and Adamts18-wildtype (MMTV)-Her2/ErbB2/Neu+ transgenic mice (i.e., Her2t/w/Adamts18+/+). The underlying mechanisms by which ADAMTS18 regulates HER2-positive tumorigenesis and metastasis were investigated by pathology, cell culture, Western blot and immunochemistry. Results: Adamts18 mRNA is mainly expressed in myoepithelial cells of the mammary duct. ADAMTS18 deficiency leads to a significantly increased incidence of mammary tumors and metastasis, as well as mammary hyperplasia in mice, over 30 months of observation. The proliferation, migration and invasion capacities of primary Her2t/w/Adamts18−/− mammary tumor cells are significantly higher than those of primary Her2t/w/Adamts18+/+ mammary tumor cells in vitro. At 30 months of age, the expression levels of laminin (LNα5), fibronectin (FN) and type I collagen (ColI) in the mammary glands of Her2t/w/Adamts18−/− mice are significantly increased, and the activities of integrin-mediated PI3K/AKT, ERK and JNK signaling pathways are enhanced. Conclusions: ADAMTS18 deficiency leads to alterations in mammary ECM components (e.g., LNα5, FN, ColI), which are associated with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
- 29 January 2024
- Published by Springer Nature in Breast Cancer Research
- Vol. 26 (1) , 1-14
Open AccessADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis
Background: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer accounts for about 20% of all breast cancer cases and is correlated with a high relapse rate and poor prognosis. ADAMTS18 is proposed as an important functional tumor suppressor gene involved in multiple malignancies, including breast cancer. It functions as an extracellular matrix (ECM) modifier. However, it remains unclear whether ADAMTS18 affects mammary tumorigenesis and malignant progression through its essential ECM regulatory function. Methods: To elucidate the role of ADAMTS18 in HER2-positive mammary tumorigenesis and metastasis in vivo, we compared the incidence of mammary tumor and metastasis between Adamts18-knockout (MMTV)-Her2/ErbB2/Neu+ transgenic mice (i.e., Her2t/w/Adamts18−/−) and Adamts18-wildtype (MMTV)-Her2/ErbB2/Neu+ transgenic mice (i.e., Her2t/w/Adamts18+/+). The underlying mechanisms by which ADAMTS18 regulates HER2-positive tumorigenesis and metastasis were investigated by pathology, cell culture, Western blot and immunochemistry. Results: Adamts18 mRNA is mainly expressed in myoepithelial cells of the mammary duct. ADAMTS18 deficiency leads to a significantly increased incidence of mammary tumors and metastasis, as well as mammary hyperplasia in mice, over 30 months of observation. The proliferation, migration and invasion capacities of primary Her2t/w/Adamts18−/− mammary tumor cells are significantly higher than those of primary Her2t/w/Adamts18+/+ mammary tumor cells in vitro. At 30 months of age, the expression levels of laminin (LNα5), fibronectin (FN) and type I collagen (ColI) in the mammary glands of Her2t/w/Adamts18−/− mice are significantly increased, and the activities of integrin-mediated PI3K/AKT, ERK and JNK signaling pathways are enhanced. Conclusions: ADAMTS18 deficiency leads to alterations in mammary ECM components (e.g., LNα5, FN, ColI), which are associated with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
- 28 February 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 218, 109020
ADAMTS18 regulates early branching morphogenesis of lacrimal gland and has a significant association with the risk of dry eye in mice
- 28 February 2022
- Published by Elsevier in Experimental Eye Research
- Vol. 218, 109020
ADAMTS18 regulates early branching morphogenesis of lacrimal gland and has a significant association with the risk of dry eye in mice
- 1 September 2021
- Published by Elsevier in Reproductive Biology
- Vol. 21 (3) , 100542
ADAMTS18 deficiency leads to preputial gland hypoplasia and fibrosis in male mice
- 1 September 2021
- Published by Elsevier in Reproductive Biology
- Vol. 21 (3) , 100542
ADAMTS18 deficiency leads to preputial gland hypoplasia and fibrosis in male mice
- 1 September 2021
- Published by Elsevier in Reproductive Biology
- Vol. 21 (3) , 100537
ADAMTS18 regulates vaginal opening through influencing the fusion of Mullerian duct and apoptosis of vaginal epithelial cells in mice
- 1 September 2021
- Published by Elsevier in Reproductive Biology
- Vol. 21 (3) , 100537
ADAMTS18 regulates vaginal opening through influencing the fusion of Mullerian duct and apoptosis of vaginal epithelial cells in mice